Biology Reference
In-Depth Information
References
1. Kuehnert, M. J., Kruszon-Moran, D., Hill, H. A., McQuillan, G., McAllister, S. K.,
Forsheim, G., McDougal, L. K., Chaitram, J., Jensen, B., Fridkin, S. K.,
Killgore, G., and Tenover, F. C. (2006) Prevalence of
Staphylococcus aureus
nasal
colonization in the United States, 2001-2002.
J. Infect. Dis
.
193
, 172-179.
2. Kluytmans, J., van Belkum, A., and Verbrugh, H. (1997) Nasal carriage of
Staphy-
lococcus aureus
: epidemiology, underlying mechanisms, and associated risks.
Clin.
Microbiol. Rev
.
10
, 505-520.
3. White, A. and Smith, J. (1963) Nasal reservoir as the source of extranasal staphy-
lococci.
Antimicrob. Agents Chemother
.
3
, 679-683.
4. Polgreen, P. M. and Herwaldt, L. A. (2004)
Staphylococcus aureus
colonization
and nosocomial infections: implications for prevention.
Curr. Infect. Dis. Rep
.
6
,
435-441.
5. Yu, V. L., Goetz, A., Wagener, M., Smith, P. B., Rihs, J. D., Hanchett, J., and
Zuravleff, J. J. (1986)
Staphylococcus aureus
nasal carriage and infection in patients
on hemodialysis.
N. Engl. J. Med
.
315
, 91-96.
6. von Eiff, C., Becker, K., Machka, K., Stammer, H., and Peters, G. (2001) Nasal
carriage as a source of
Staphylococcus aureus
bacteremia.
N. Engl. J. Med
.
344
,
11-16.
7. Corne, P., Marchandin, H., Jonquet, O., Campos, J., and Banuls, A.-L. (2005)
Molecular evidence that nasal carriage of
Staphylococcus aureus
plays a role in respi-
ratory tract infections of critically ill patients.
J. Clin. Microbiol
.
43
, 3491-3493.
8. Kowalski, T. J., Berbari, E. F., and Osmon, D. R. (2005) Epidemiology, treatment
and prevention of community-acquired methicillin-resistant
Staphylococcus aureus
infections.
Mayo Clin. Proc
.
80
, 1201-1208.
9. Kluytmans, J. A., Mouton, J. W., Vandenbergh, M., Manders, M.-J., Maat, A.,
Wagenvoort, J., Michel, M., and Verbrugh, H. (1996) Reduction of surgical-site
infections in cardiothoracic surgery by elimination of nasal carriage of
Staphylo-
coccus aureus
.
Infect. Control Hosp. Epidemiol
.
17
, 780-785.
10. Perl, T., Cullen, J., Wenzel, R., Zimmerman, B., Pfaller, M., Sheppard, D.,
Twombley, J., French, P., and Herwalt, L. (2002) Intranasal mupirocin to prevent
postoperative
Staphylococcus aureus
infections.
N. Engl. J. Med
.
24
, 1871-1877.
11. Martin, J., Perdreau-Remington, F., Kartalija, M., Pasi, O., Webb, M.,
Gerberding, J., Chambers, H., Tauber, M., and Lee, B. (1999) A randomized clinical
trial of mupirocin in the eradication of
Staphylococcus aureus
nasal carriage in
human immunodeficiency virus disease.
J. Infect. Dis
.
180
, 896-899.
12. Wertheim, H. F. L., Vos, M. C., Ott, A., Voss, A., Kluytmans, J. A. J. W.,
Vandenbroucke-Grauls, C. M. J. E., Meester, M. H. M., van Keulen, P. H. J., and
Verbrugh, H. A. (2004) Mupirocin prophylaxis against nosocomial
Staphylococcus
aureus
infections in nonsurgical patients.
Ann. Intern. Med
.
140
, 419-425.
13. Yano, M., Doki, Y., Inoue, M., Tsujinaka, T., Shiozaki, H., and Monden, M.
(2000) Preoperative intranasal mupirocin ointment significantly reduces postoper-
ative infection with
Staphylococcus aureus
in patients undergoing upper gastroin-
testinal surgery.
Surg. Today (Japan)
30
, 16-21.
Search WWH ::
Custom Search